R3HDML
Peptidase inhibitor R3HDML
Also known as: CRSPL_HUMAN, dJ881L22.3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H3Y0
- Gene
- R3HDML
- Ensembl
- ENSG00000101074
- Chromosome
- 20
- Canonical length
- 253 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to enable peptidase inhibitor activity. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
253 residues, UniProt reviewed canonical sequence.
>Q9H3Y0|R3HDML
1 MPLLPSTVGL AGLLFWAGQA VNALIMPNAT PAPAQPESTA MRLLSGLEVP RYRRKRHISV
61 RDMNALLDYH NHIRASVYPP AANMEYMVWD KRLARAAEAW ATQCIWAHGP SQLMRYVGQN
121 LSIHSGQYRS VVDLMKSWSE EKWHYLFPAP RDCNPHCPWR CDGPTCSHYT QMVWASSNRL
181 GCAIHTCSSI SVWGNTWHRA AYLVCNYAIK GNWIGESPYK MGKPCSSCPP SYQGSCNSNM
241 CFKGLKSNKF TWFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against R3HDML can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 2.3 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 2.3 nTPM
- duodenum: 2 nTPM
- colon: 0.7 nTPM
- stomach: 0.4 nTPM
- testis: 0.4 nTPM
- appendix: 0.3 nTPM
Single-cell type
- enteric stem cells: 16 nCPM
- paneth cells: 12 nCPM
- tuft cells: 12 nCPM
- enteric transient amplifying cells: 5.7 nCPM
- enterocytes: 3.6 nCPM
- colonocytes: 3.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 1.4 nTPM
- white matter: 1.4 nTPM
- thalamus: 1.3 nTPM
- cerebellum: 1.1 nTPM
- cerebral cortex: 1.1 nTPM
- medulla oblongata: 1.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.55
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine-rich secretory protein-related
- CAP domain
- CAP superfamily
- Cysteine-rich secretory protein family
- Peptidase inhibitor R3HDML, CAP domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads R3HDML as an antibody target. Whether an autoantibody or antibody against R3HDML could matter depends on whether native R3HDML is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
R3HDML is annotated as secreted, so native R3HDML circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label R3HDML as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...